Discover
OMDA
Omada Health
24.17
1 x 24.18
1 x 24.24
bid
ask
-
0.82
3.29%
12:34 PM
timesize
| Ytd | 53.16% | |
| 1y | 26.80% |
23.78
day range
25.09
10.28
52 week range
26.91
| Open | 24.75 | Prev Close | 24.99 | Low | 23.78 | High | 25.09 | Mkt Cap | 1.43B |
| Vol | 673.31K | Avg Vol | 1.30M | EPS | 0.07 | P/E | 343.95 | Forward P/E | 44.54 |
| Beta | 1.73 | Short Ratio | 6.71 | Inst. Own | 80.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 20.41 | 200-d Avg | 16.94 | 1yr Est | 25.67 |
| Income Statement | |||
| Total Revenue | 87.84M | ||
| Revenues (USD) | 87.84M | ||
| Cost of Revenue | 24.05M | ||
| Gross Profit | 63.79M | ||
| Operating Expenses | 60.24M | ||
| Research and Development Expense | 14.63M | ||
| Selling, General and Administrative Expense | 45.61M | ||
| Operating Income | 3.55M | ||
| Interest Expense | 14.00K | ||
| Net Income | 5.29M | ||
| Net Income Common Stock | 5.29M | ||
| Net Income Common Stock (USD) | 5.29M | ||
| Consolidated Income | 5.29M | ||
| Earnings per Basic Share | 0.09 | ||
| Earnings per Basic Share (USD) | 0.09 | ||
| Earnings per Diluted Share | 0.08 | ||
| Earning Before Interest & Taxes (EBIT) | 5.31M | ||
| Earning Before Interest & Taxes (USD) | 5.31M | ||
| Weighted Average Shares | 59.69M | ||
| Weighted Average Shares Diluted | 63.95M | ||
| Balance Sheet | |||
| Cash and Equivalents | 221.71M | ||
| Cash and Equivalents (USD) | 221.71M | ||
| Trade and Non-Trade Receivables | 56.57M | ||
| Current Assets | 294.91M | ||
| Property, Plant & Equipment Net | 9.10M | ||
| Total Assets | 328.22M | ||
| Current Liabilities | 75.48M | ||
| Total Liabilities | 75.48M | ||
| Accumulated Retained Earnings (Deficit) | -454.42M | ||
| Shareholders Equity | 252.74M | ||
| Shareholders Equity (USD) | 252.74M | ||
| Assets Non-Current | 33.31M | ||
| Deferred Revenue | 27.70M | ||
| Goodwill and Intangible Assets | 14.78M | ||
| Inventory | 4.12M | ||
| Trade and Non-Trade Payables | 11.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.58M | ||
| Net Cash Flow from Financing | 7.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.95M | ||
| Capital Expenditure | -1.66M | ||
| Issuance (Purchase) of Equity Shares | 8.14M | ||
| Net Cash Flow from Investing | -1.66M | ||
| Net Cash Flow from Operations | 4.01M | ||
| Share Based Compensation | 5.63M | ||